{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T10:28:55Z","timestamp":1787048935653,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41390-025-04492-1","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:14:30Z","timestamp":1763572470000},"page":"2802-2809","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hepatoblastoma: an investigation of diagnostic, prognostic, and therapeutic gene targets and biomarkers"],"prefix":"10.1038","volume":"99","author":[{"given":"Sarah","family":"Voskamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Elizabeth","family":"Speck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"4492_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29763","volume":"69","author":"JA Kahla","year":"2022","unstructured":"Kahla, J. A. et al. Incidence and 5-year survival of children and adolescents with hepatoblastoma in the United States. Pediatr. Blood Cancer 69, e29763 (2022).","journal-title":"Pediatr. Blood Cancer"},{"key":"4492_CR2","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/pbc.24215","volume":"59","author":"LG Spector","year":"2012","unstructured":"Spector, L. G. & Birch, J. The epidemiology of hepatoblastoma. Pediatr. Blood Cancer 59, 776\u2013779 (2012).","journal-title":"Pediatr. Blood Cancer"},{"key":"4492_CR3","doi-asserted-by":"publisher","first-page":"445","DOI":"10.5582\/bst.2023.01311","volume":"17","author":"Y Cao","year":"2023","unstructured":"Cao, Y., Wu, S. & Tang, H. An update on diagnosis and treatment of hepatoblastoma. Biosci. Trends 17, 445\u2013457 (2023).","journal-title":"Biosci. Trends"},{"key":"4492_CR4","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/pbc.24213","volume":"59","author":"GE Tomlinson","year":"2012","unstructured":"Tomlinson, G. E. & Kappler, R. Genetics and epigenetics of hepatoblastoma. Pediatr. Blood Cancer 59, 785\u2013792 (2012).","journal-title":"Pediatr. Blood Cancer"},{"key":"4492_CR5","doi-asserted-by":"publisher","unstructured":"Lim, I. I. P., Bondoc, A. J., Geller, J. I. & Tiao, G. M. Hepatoblastoma-the evolution of biology, surgery, and transplantation. Children (Basel) 6 https:\/\/doi.org\/10.3390\/children6010001 (2018).","DOI":"10.3390\/children6010001"},{"key":"4492_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-024-10764-y","author":"TFM Aguiar","year":"2024","unstructured":"Aguiar, T. F. M. et al. First transcriptome analysis of hepatoblastoma in Brazil: unraveling the pivotal role of noncoding RNAs and metabolic pathways. Biochem. Genet. https:\/\/doi.org\/10.1007\/s10528-024-10764-y (2024).","journal-title":"Biochem. Genet."},{"key":"4492_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13052-020-00877-6","volume":"46","author":"G Shen","year":"2020","unstructured":"Shen, G., Shen, H., Zhang, J., Yan, Q. & Liu, H. DNA methylation in Hepatoblastoma-a literature review. Ital. J. Pediatr. 46, 113 (2020).","journal-title":"Ital. J. Pediatr."},{"key":"4492_CR8","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.humpath.2012.08.003","volume":"44","author":"C-T Lee","year":"2013","unstructured":"Lee, C.-T., Zhang, L., Mounajjed, T. & Wu, T.-T. High mobility group AT-hook 2 is overexpressed in hepatoblastoma. Hum. Pathol. 44, 802\u2013810 (2013).","journal-title":"Hum. Pathol."},{"key":"4492_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/modpathol.3800977","volume":"21","author":"MC Curia","year":"2008","unstructured":"Curia, M. C. et al. Sporadic childhood hepatoblastomas show activation of \u03b2-catenin, mismatch repair defects and p53 mutations. Mod. Pathol. 21, 7\u201314 (2008).","journal-title":"Mod. Pathol."},{"key":"4492_CR10","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s11912-022-01230-2","volume":"24","author":"PV Wu","year":"2022","unstructured":"Wu, P. V. & Rangaswami, A. Current approaches in hepatoblastoma\u2014new biological insights to inform therapy. Curr. Oncol. Rep. 24, 1209\u20131218 (2022).","journal-title":"Curr. Oncol. Rep."},{"key":"4492_CR11","doi-asserted-by":"publisher","first-page":"e85599","DOI":"10.1371\/journal.pone.0085599","volume":"9","author":"R Dong","year":"2014","unstructured":"Dong, R. et al. Genome-wide analysis of long noncoding RNA (lncRNA) expression in hepatoblastoma tissues. PLoS One 9, e85599 (2014).","journal-title":"PLoS One"},{"key":"4492_CR12","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jhep.2020.03.025","volume":"73","author":"J Carrillo-Reixach","year":"2020","unstructured":"Carrillo-Reixach, J. et al. Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications. J. Hepatol. 73, 328\u2013341 (2020).","journal-title":"J. Hepatol."},{"key":"4492_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/hep.28888","volume":"65","author":"P Sumazin","year":"2017","unstructured":"Sumazin, P. et al. Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups. Hepatology 65, 104\u2013121 (2017).","journal-title":"Hepatology"},{"key":"4492_CR14","doi-asserted-by":"publisher","DOI":"10.31487\/j.EJMC.2018.01.003","author":"YU Eiso Hiyama","year":"2019","unstructured":"Eiso Hiyama, Y. U. Gene expression profiling in hepatoblastoma cases of the Japanese Study Group for Pediatric Liver Tumors-2 (JPLT-2) trial. Eur. J. Mol. Cancer https:\/\/doi.org\/10.31487\/j.EJMC.2018.01.003 (2019).","journal-title":"Eur. J. Mol. Cancer"},{"key":"4492_CR15","doi-asserted-by":"publisher","unstructured":"Hadley, D. et al. Precision annotation of digital samples in NCBI\u2019s gene expression omnibus. Sci. Data 4 https:\/\/doi.org\/10.1038\/sdata.2017.125 (2017).","DOI":"10.1038\/sdata.2017.125"},{"key":"4492_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.778","volume":"12","author":"L Liu","year":"2022","unstructured":"Liu, L. et al. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma. Clin. Transl. Med. 12, e778 (2022).","journal-title":"Clin. Transl. Med."},{"key":"4492_CR17","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00432-020-03182-1","volume":"146","author":"I Regel","year":"2020","unstructured":"Regel, I. et al. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations. J. Cancer Res. Clin. Oncol. 146, 1153\u20131167 (2020).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"4492_CR18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/01.LAB.0000059926.66359.BD","volume":"83","author":"O Wirths","year":"2003","unstructured":"Wirths, O. et al. Overexpression of Human Dickkopf-1, an Antagonist of wingless\/WNT Signaling, in Human Hepatoblastomas and Wilms\u2019 Tumors. Lab. Invest. 83, 429\u2013434 (2003).","journal-title":"Lab. Invest."},{"key":"4492_CR19","doi-asserted-by":"publisher","first-page":"e17794","DOI":"10.1371\/journal.pone.0017794","volume":"6","author":"Y Li","year":"2011","unstructured":"Li, Y. et al. ShRNA-targeted centromere protein A inhibits hepatocellular carcinoma growth. PLoS One 6, e17794 (2011).","journal-title":"PLoS One"},{"key":"4492_CR20","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1128\/MCB.00276-12","volume":"33","author":"RM Gill","year":"2013","unstructured":"Gill, R. M., Gabor, T. V., Couzens, A. L. & Scheid, M. P. The MYC-associated protein CDCA7 is phosphorylated by AKT to regulate MYC-dependent apoptosis and transformation. Mol. Cell. Biol. 33, 498\u2013513 (2013).","journal-title":"Mol. Cell. Biol."},{"key":"4492_CR21","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3109\/09537104.2015.1095877","volume":"27","author":"L Nissinen","year":"2016","unstructured":"Nissinen, L. et al. Platelet response to a small molecule inhibitor of \u03b12\u03b21 integrin is associated with ITGA2 C807T dimorphism. Platelets 27, 378\u2013380 (2016).","journal-title":"Platelets"},{"key":"4492_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.mce.2018.10.014","volume":"489","author":"W Su","year":"2019","unstructured":"Su, W. et al. Role of HSD17B13 in the liver physiology and pathophysiology. Mol. Cell. Endocrinol. 489, 119\u2013125 (2019).","journal-title":"Mol. Cell. Endocrinol."},{"key":"4492_CR23","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/jb\/mvaa013","volume":"167","author":"Y Tang","year":"2020","unstructured":"Tang, Y., Ma, N., Luo, H., Chen, S. & Yu, F. Downregulated long non-coding RNA LINC01093 in liver fibrosis promotes hepatocyte apoptosis via increasing ubiquitination of SIRT1.  J. Biochem. 167, 525\u2013534 (2020).","journal-title":"J. Biochem."},{"key":"4492_CR24","volume":"2022","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Hydroxyacid Oxidase 2 (HAO2) inhibits the tumorigenicity of hepatocellular carcinoma and is negatively regulated by miR-615-5p. J. Immunol. Res. 2022, 5003930 (2022).","journal-title":"J. Immunol. Res."},{"key":"4492_CR25","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/jso.23440","volume":"108","author":"H Takami","year":"2013","unstructured":"Takami, H. et al. Evaluation of MAGE-D4 expression in hepatocellular carcinoma in Japanese patients. J. Surg. Oncol. 108, 557\u2013562 (2013).","journal-title":"J. Surg. Oncol."},{"key":"4492_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.889","volume":"12","author":"RA Hill","year":"2022","unstructured":"Hill, R. A. & Liu, Y. Y. N. (6) -methyladenosine-RNA methylation promotes expression of solute carrier family 7 member 11, an uptake transporter of cystine for lipid reactive oxygen species scavenger glutathione synthesis, leading to hepatoblastoma ferroptosis resistance. Clin. Transl. Med. 12, e889 (2022).","journal-title":"Clin. Transl. Med."},{"key":"4492_CR27","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.humpath.2008.07.022","volume":"40","author":"D L\u00f3pez-Terrada","year":"2009","unstructured":"L\u00f3pez-Terrada, D. et al. Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors. Hum. Pathol. 40, 783\u2013794 (2009).","journal-title":"Hum. Pathol."},{"key":"4492_CR28","doi-asserted-by":"publisher","unstructured":"Sha, Y. L., Liu, S., Yan, W. W. & Dong, B. Wnt\/\u03b2-catenin signaling as a useful therapeutic target in hepatoblastoma. Biosci. Rep. 39 https:\/\/doi.org\/10.1042\/bsr20192466 (2019).","DOI":"10.1042\/bsr20192466"},{"key":"4492_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3040839","volume":"2020","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. The oncogenic role of CENPA in hepatocellular carcinoma development: evidence from bioinformatic analysis. Biomed. Res. Int. 2020, 3040839 (2020).","journal-title":"Biomed. Res. Int."},{"key":"4492_CR30","doi-asserted-by":"publisher","unstructured":"Parisi, S., Piscitelli, S., Passaro, F. & Russo, T. HMGa proteins in stemness and differentiation of embryonic and adult stem cells. Int. J. Mol. Sci. 21 https:\/\/doi.org\/10.3390\/ijms21010362 (2020).","DOI":"10.3390\/ijms21010362"},{"key":"4492_CR31","doi-asserted-by":"publisher","unstructured":"Mansoori, B. et al. HMGA2 as a Critical Regulator in Cancer Development. Genes (Basel) 12 https:\/\/doi.org\/10.3390\/genes12020269 (2021).","DOI":"10.3390\/genes12020269"},{"key":"4492_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00432-020-03378-5","volume":"147","author":"OY Burenina","year":"2021","unstructured":"Burenina, O. Y. et al. Panel of potential lncRNA biomarkers can distinguish various types of liver malignant and benign tumors. J. Cancer Res. Clin. Oncol. 147, 49\u201359 (2021).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"4492_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.591507","volume":"11","author":"R Sun","year":"2021","unstructured":"Sun, R., Li, S., Zhao, K., Diao, M. & Li, L. Identification of ten core hub genes as potential biomarkers and treatment target for hepatoblastoma. Front Oncol. 11, 591507 (2021).","journal-title":"Front Oncol."},{"key":"4492_CR34","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvae015","volume":"8","author":"B Brie","year":"2024","unstructured":"Brie, B. et al. Modifications of the GH axis reveal unique sexually dimorphic liver signatures for Lcn13, Asns, Hamp2, Hao2, and Pgc1a. J. Endocr. Soc. 8, bvae015 (2024).","journal-title":"J. Endocr. Soc."},{"key":"4492_CR35","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.7150\/ijbs.95484","volume":"20","author":"R Liang","year":"2024","unstructured":"Liang, R. et al. Seleno-amino acid metabolism reshapes the tumor microenvironment: from cytotoxicity to immunotherapy. Int. J. Biol. Sci. 20, 2779\u20132789 (2024).","journal-title":"Int. J. Biol. Sci."},{"key":"4492_CR36","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/S0140-6736(11)61452-9","volume":"379","author":"MP Rayman","year":"2012","unstructured":"Rayman, M. P. Selenium and human health.  Lancet 379, 1256\u20131268 (2012).","journal-title":"Lancet"},{"key":"4492_CR37","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s42255-020-0224-7","volume":"2","author":"AE Carlisle","year":"2020","unstructured":"Carlisle, A. E. et al. Selenium detoxification is required for cancer-cell survival. Nat. Metab. 2, 603\u2013611 (2020).","journal-title":"Nat. Metab."},{"key":"4492_CR38","doi-asserted-by":"publisher","first-page":"9038","DOI":"10.1158\/0008-5472.CAN-05-0882","volume":"65","author":"S Emanuel","year":"2005","unstructured":"Emanuel, S. et al. The In vitro and In vivo effects of JNJ-7706621: a dual inhibitor of cyclin-dependent kinases and aurora kinases. Cancer Res. 65, 9038\u20139046 (2005).","journal-title":"Cancer Res."},{"key":"4492_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10293-0","volume":"22","author":"M Singha","year":"2022","unstructured":"Singha, M. et al. Artificial intelligence to guide precision anticancer therapy with multitargeted kinase inhibitors. BMC Cancer 22, 1211 (2022).","journal-title":"BMC Cancer"},{"key":"4492_CR40","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1590\/1414-431x20154400","volume":"48","author":"BL Xu","year":"2015","unstructured":"Xu, B. L., Zhao, Q. Z., Gao, X. Y. & Hou, G. J. Effect of estradiol and bisphenol A on human hepatoblastoma cell viability and telomerase activity. Braz. J. Med. Biol. Res. 48, 1004\u20131009 (2015).","journal-title":"Braz. J. Med. Biol. Res."},{"key":"4492_CR41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1478-3231.2004.00887.x","volume":"24","author":"S Brandt","year":"2004","unstructured":"Brandt, S., Heller, H., Schuster, K.-D. & Grote, J. Tamoxifen induces suppression of cell viability and apoptosis in the human hepatoblastoma cell line HepG2 via down-regulation of telomerase activity. Liver Int. 24, 46\u201354 (2004).","journal-title":"Liver Int."},{"key":"4492_CR42","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s00432-004-0589-0","volume":"131","author":"S Brandt","year":"2005","unstructured":"Brandt, S., Heller, H., Schuster, K.-D. & Grote, J. The tamoxifen-induced suppression of telomerase activity in the human hepatoblastoma cell line HepG2: a result of post-translational regulation. J. Cancer Res. Clin. Oncol. 131, 120\u2013128 (2005).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"4492_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-020-0125-y","volume":"4","author":"M Sekiguchi","year":"2020","unstructured":"Sekiguchi, M. et al. Integrated multiomics analysis of hepatoblastoma unravels its heterogeneity and provides novel druggable targets. npj Precis. Oncol. 4, 20 (2020).","journal-title":"npj Precis. Oncol."},{"key":"4492_CR44","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1002\/cbin.11624","volume":"45","author":"C Pang","year":"2021","unstructured":"Pang, C. et al. C\/EBP\u03b2 enhances efficacy of sorafenib in hepatoblastoma. Cell Biol. Int. 45, 1897\u20131905 (2021).","journal-title":"Cell Biol. Int."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04492-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04492-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04492-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T10:00:58Z","timestamp":1787047258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04492-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4492"],"URL":"https:\/\/doi.org\/10.1038\/s41390-025-04492-1","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}